Selected representations include:
- Ceva Santé Animale and Horizon Valley Generics in a contract and Lanham Act litigation involving fipronil/methoprene veterinary products in the Middle District of Georgia.
- West-Ward Pharmaceutical in Hatch-Waxman patent infringement litigation brought by Spectrum Pharmaceuticals in the District of Nevada involving patents concerning the drug product Fusilev® (levoleucovorin).
- Teva Pharmaceuticals USA in Hatch-Waxman patent infringement litigation involving patents listed in the Orange Book and processes for SUBOXONE® (buprenorphine/naloxone sublingual film). Reckitt Benckiser et al v. Teva Pharmaceuticals USA.
- Watson Laboratories and Andrx Labs in Hatch-Waxman patent infringement litigation involving patents listed in the Orange Book for OXYCONTIN® (extended-release oxycodone hydrochloride tablets). Case settled before trial. Purdue Pharma et al. v. Watson Laboratories et al. (S.D.N.Y.).
Mr. Stull is a member of the American Intellectual Property Law Association (AIPLA) and the Federal Circuit Bar Association.
Prior to joining Goodwin in 2014, Mr. Stull was an associate in the Washington, D.C. office of Kenyon & Kenyon.